» Articles » PMID: 35958484

Promoting the Formation of Pi-stacking Interaction to Improve CTL Cells Activation Between Modified Peptide and HLA

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2022 Aug 12
PMID 35958484
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aims to investigate the use of single residue substitution to promote the formation of pi-stacking interactions between peptides and Human leukocyte antigen (HLA)-A*2402 molecules to improve the affinity of peptides and HLA molecules, as well as the level of cytotoxic T lymphocyte (CTL) cells activated by peptides-HLA (p-HLA) complex.

Methods: Molecular docking and molecular dynamics simulation were used to simulate and analyze the interactions and binding free energies between HLA-A*2402-restricted antigen peptides and HLA molecules, before and after the single residue substitution. HLA-A*2402 restricted antigen peptides before and after the single residue replacement were loaded into dendritic cells (DCs) in vitro, and further Enzyme-Linked ImmunoSpot (ELispot) test was carried out to evaluate the effect of modified antigen peptides on the immune activation of CTL cells.

Result: After replacing the antigen peptides with a single residue, some of them could promote the formation of pi-stacking interaction. The binding free energy between the modified antigen peptides and HLA-A*2402, as well as the level of immune activation of CTL cells were mostly higher than before, especially after the replacement of the 9th residue of the polypeptide, such as C9F and C9W. There was a significant negative correlation between the level of activated CTL cells by modified antigen peptides and the total interaction amount of hydrogen bonds and salt bridges.

Conclusion: Promoting the formation of pi-stacking interaction between antigen peptides and HLA-A*2402 molecules could increase the total binding free energy of p-HLA complex and the level of CTL cells activation. In addition, the amount of hydrogen bonds and salt bridges between peptides and HLA could reduce the level of immune activation. All the characteristics above can improve the immunogenicities of the weak antigens.

Citing Articles

Small Molecule Compound DHPA Screened by Computer-Aided Drug Design and Molecular Dynamics Simulation Inhibits Neuroblastoma Cell Proliferation by Targeting TrkB.

Liu T, Yin H, Hu Q, Dong X, Xin B, Wu Y ACS Omega. 2024; 9(41):42227-42244.

PMID: 39431081 PMC: 11483404. DOI: 10.1021/acsomega.4c04528.

References
1.
Boehm K, Bhinder B, Raja V, Dephoure N, Elemento O . Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome. BMC Bioinformatics. 2019; 20(1):7. PMC: 6321722. DOI: 10.1186/s12859-018-2561-z. View

2.
Mei S, Li F, Leier A, Marquez-Lago T, Giam K, Croft N . A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction. Brief Bioinform. 2019; 21(4):1119-1135. PMC: 7373177. DOI: 10.1093/bib/bbz051. View

3.
ODonnell T, Rubinsteyn A, Laserson U . MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing. Cell Syst. 2020; 11(1):42-48.e7. DOI: 10.1016/j.cels.2020.06.010. View

4.
Hoffmann M, Slansky J . T-cell receptor affinity in the age of cancer immunotherapy. Mol Carcinog. 2020; 59(7):862-870. PMC: 7340130. DOI: 10.1002/mc.23212. View

5.
Rech A, Balli D, Mantero A, Ishwaran H, Nathanson K, Stanger B . Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer. Cancer Immunol Res. 2018; 6(3):276-287. PMC: 6047936. DOI: 10.1158/2326-6066.CIR-17-0559. View